are obligated to provide CRA access to the EMR only for subjects enrolled in the clinical trial, in a read-only and secure format.

Key Benefits of EMR-Based SDV

• Improved Accessibility: Data is centralized and can be accessed from site-controlled terminals.
• Legibility: Digital records eliminate handwriting interpretation errors common with paper charts.
• Structured Data: Lab results, diagnoses, and prescriptions are often coded and timestamped, improving data precision.
• Audit Trails: EMRs typically log every access, supporting inspection readiness.

Challenges with SDV in EMRs

• Restricted CRA access due to hospital IT policies
• Data spread across multiple modules (progress notes, labs, orders)
• Potential exposure to PHI unrelated to the study
• Navigation complexities due to varied EMR systems
• Limited training resources for CRAs on EMR platforms

Gaining Access to EMR Systems

Before conducting SDV, CRAs should be granted access based on pre-approved site policies. Ideally, access should be:

• Time-limited: Access should be active only for the scheduled monitoring period.
• Read-only: CRAs must not modify any EMR records.
• Audit-enabled: EMR access logs should track who accessed what and when.
• Subject-restricted: CRAs must only access charts of study participants.

Site IT departments typically create temporary user profiles for CRAs. If a secure, dedicated monitoring terminal is available, this is preferred. The CRA must log out at the end of the session, and site staff should confirm session termination.

Preparing for SDV in EMR Systems

1. Obtain a list of enrolled subjects, with subject IDs and corresponding MRNs (masked).
2. Coordinate with site staff to preload records or guide navigation.
3. Request a quick tutorial or EMR guide from the site (usually 10–15 mins).
4. Prepare a checklist of critical data points for SDV: Informed Consent, Inclusion/Exclusion criteria, AE/SAEs, IP administration, lab data.
5. Ensure your Pharma SOP documentation aligns with electronic source data verification procedures.

Steps for Conducting SDV in EMRs

1. Locate Subject Chart

Use the subject enrollment log and protocol-assigned ID. Never use or record identifiable patient information such as full names or medical record numbers.

2. Review Informed Consent Documentation

• Confirm the version number and date match the protocol version
• Verify subject and investigator signatures and date alignment
• Check consent was obtained before any study-specific procedure

3. Verify Inclusion/Exclusion Criteria

Use EMR lab results, vitals, and clinical notes to verify eligibility. Document findings as “criteria confirmed” or note discrepancies in EDC queries.

4. Review AE/SAE Data

Match Adverse Event (AE) entries in CRFs with EMR progress notes or discharge summaries. Verify onset dates, relatedness, severity, and outcomes.

5. Check IP Dosing and Administration Records

Confirm investigational product was administered as per the protocol. Cross-check EMR medication orders with pharmacy logs if needed.

6. Validate Laboratory Results

Ensure correct dates, units, and reference ranges are documented. Check against CRF entries for transcription accuracy.

7. Confirm Visit Dates and Timing Windows

Use appointment and visit timestamps in EMR to validate protocol-defined visit schedules.

Privacy and Data Confidentiality Measures

To maintain subject confidentiality, CRAs should:

• Never print, copy, or screenshot EMR content
• Avoid writing down any identifiers, including initials or MRNs
• Summarize findings in SDV logs with de-identified subject IDs
• Ensure logout from EMR after SDV is complete

For additional guidance, visit Stability Studies which offers best practices for handling sensitive trial data securely.

Documentation in Monitoring Visit Reports (MVR)

CRAs must clearly describe the scope of SDV in the MVR. Include:

• Subjects verified with EMR
• Modules accessed (e.g., Labs, Notes, Orders)
• Summary of findings and resolution status
• Any site or system issues encountered

Audit Readiness and Regulatory Expectations

Authorities such as MHRA and CDSCO increasingly inspect SDV processes in EMRs during audits. Sites and sponsors should ensure:

• CRA access logs are stored and retrievable
• SOPs reflect digital SDV practices
• Training records of CRAs in EMR systems are maintained
• Monitoring reports document secure access and findings

Tips for Efficient SDV in EMRs

• Use dual screens (if available) for faster data verification
• Leverage EMR search tools (e.g., filters, keywords)
• Prioritize critical data points to save time
• Ask for tech support if stuck in navigation

Conclusion

EMR-based SDV is a cornerstone of modern clinical monitoring. With appropriate planning, training, and adherence to data protection norms, CRAs can perform accurate, compliant, and efficient SDV even in complex digital environments. Sponsors and sites must collaborate to ensure systems are EMR-ready for trials and align SOPs with the realities of eSource verification.